Graphite Bio, Inc.
Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly co…
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
Graphite Bio, Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
Graphite Bio, Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of Graphite Bio, Inc..